Published in Nephrol Dial Transplant on July 01, 2006
An integrated review of "unplanned" dialysis initiation: reframing the terminology to "suboptimal" initiation. BMC Nephrol (2009) 1.05
Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit Dial Int (2011) 0.94
Effect of an in-hospital chronic kidney disease education program among patients with unplanned urgent-start dialysis. Clin J Am Soc Nephrol (2011) 0.92
Inpatient hemodialysis initiation: reasons, risk factors and outcomes. Nephron Clin Pract (2009) 0.89
The impact of patient preference on dialysis modality and hemodialysis vascular access. BMC Nephrol (2014) 0.82
Status of initiating pattern of hemodialysis: a multi-center study. J Korean Med Sci (2009) 0.78
Not early referral but planned dialysis improves quality of life and depression in newly diagnosed end stage renal disease patients: a prospective cohort study in Korea. PLoS One (2015) 0.77
'Reality and desire' in the care of advanced chronic kidney disease. NDT Plus (2010) 0.76
Does wealth make health? Cherchez la renal replacement therapy. Clin Kidney J (2017) 0.75
Enabling self-management: selecting patients for home dialysis? NDT Plus (2011) 0.75
Home dialysis-an international perspective. NDT Plus (2011) 0.75
Factors Associated with the Choice of Peritoneal Dialysis in Patients with End-Stage Renal Disease. Biomed Res Int (2016) 0.75
Geographic and facility variation in initial use of non-tunneled catheters for incident maintenance hemodialysis patients. BMC Nephrol (2016) 0.75
Offering Patients Therapy Options in Unplanned Start (OPTiONS): Implementation of an educational program is feasible and effective. BMC Nephrol (2017) 0.75
Risk factors for unplanned and crash dialysis starts: a protocol for a systematic review and meta-analysis. Syst Rev (2016) 0.75
Type of Referral, Dialysis Start and Choice of Renal Replacement Therapy Modality in an International Integrated Care Setting. PLoS One (2016) 0.75
Factors influencing access to education, decision making, and receipt of preferred dialysis modality in unplanned dialysis start patients. Patient Prefer Adherence (2016) 0.75
Molecular analysis of 250 patients with autosomal recessive congenital ichthyosis: evidence for mutation hotspots in ALOXE3 and allelic heterogeneity in ALOX12B. J Invest Dermatol (2009) 2.58
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51
Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney Int (2012) 2.34
The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia. Haematologica (2006) 2.13
Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2013) 2.10
Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol (2010) 2.02
Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients. Nephrol Dial Transplant (2011) 2.02
NF-kappaB in renal inflammation. J Am Soc Nephrol (2010) 2.00
Tenofovir nephrotoxicity: 2011 update. AIDS Res Treat (2011) 1.94
Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int (2009) 1.88
Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol (2011) 1.77
Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int (2008) 1.77
Animal models of cardiovascular diseases. J Biomed Biotechnol (2011) 1.73
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler Thromb Vasc Biol (2009) 1.52
Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol (2008) 1.50
The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. J Am Soc Nephrol (2011) 1.45
Parathyroid hormone-related protein protects renal tubuloepithelial cells from apoptosis by activating transcription factor Runx2. Kidney Int (2013) 1.44
The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol (2008) 1.43
Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease. Kidney Int (2010) 1.41
[Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients]. Enferm Infecc Microbiol Clin (2009) 1.41
AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol (2011) 1.40
Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant (2006) 1.28
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy. Nephrol Dial Transplant (2010) 1.26
Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.25
The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol (2008) 1.25
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin J Am Soc Nephrol (2010) 1.24
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant (2011) 1.23
The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol (2008) 1.22
Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.22
Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol (2011) 1.21
C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol (2011) 1.21
TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis. Nephrol Dial Transplant (2009) 1.21
TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm (2010) 1.20
Pulmonary hypertension in CKD. Am J Kidney Dis (2012) 1.19
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med (2011) 1.18
Analysis of patient flow into dialysis: role of education in choice of dialysis modality. Perit Dial Int (2005) 1.16
BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant (2010) 1.15
HCV infection and miravirsen. N Engl J Med (2013) 1.14
Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.13
Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin. Stroke (2006) 1.12
Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol (2013) 1.09
TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS One (2010) 1.07
Assessment of heavy metal levels in Almendares River sediments--Havana City, Cuba. Water Res (2005) 1.07
Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. J Cell Mol Med (2009) 1.07
3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes (2005) 1.07
TWEAK, a multifunctional cytokine in kidney injury. Kidney Int (2011) 1.06
Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity. Kidney Int (2008) 1.05
Three-year clinical evaluation of In-Ceram Zirconia posterior FPDs. Int J Prosthodont (2004) 1.04
Evaluation of MLPA for the detection of cryptic subtelomeric rearrangements. J Lab Clin Med (2006) 1.03
Ultrasound guidance for lateral midfemoral sciatic nerve block: a prospective, comparative, randomized study. Anesth Analg (2007) 1.02
Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol (2012) 1.02
Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process. PLoS One (2010) 1.01
Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharm Res (2008) 1.01
Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int Suppl (2003) 1.01
3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int (2005) 1.01
Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol (2004) 1.01
CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol (2009) 1.01
TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. Biochim Biophys Acta (2013) 1.00
The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant (2010) 1.00
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury. Nephrol Dial Transplant (2010) 1.00
Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure. Kidney Int Suppl (2003) 0.98
Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am J Pathol (2004) 0.98
Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. Cardiovasc Res (2009) 0.98
Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol (2003) 0.97
Severe everolimus-associated pneumonitis in a renal transplant recipient. Nephrol Dial Transplant (2008) 0.97
Endothelial progenitor cells: a new key for endothelial dysfunction in migraine. Neurology (2012) 0.96
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest (2010) 0.96
Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations. Nephrol Dial Transplant (2009) 0.96
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis. Nephrol Dial Transplant (2008) 0.96
Do needs, symptoms or disability of outpatients with schizophrenia influence family burden? Soc Psychiatry Psychiatr Epidemiol (2008) 0.96
p-cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. Nephrol Dial Transplant (2013) 0.95
Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis (2013) 0.95
Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation. PLoS One (2008) 0.95
Is word recognition different in central and peripheral vision? Vision Res (2003) 0.95
Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit Dial Int (2011) 0.94
HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest (2011) 0.94
TWEAK and Fn14. New players in the pathogenesis of atherosclerosis. Front Biosci (2007) 0.93
Vitamin D receptor activation and cardiovascular disease. Nephrol Dial Transplant (2012) 0.93
Phosphate: a stealthier killer than previously thought? Cardiovasc Pathol (2012) 0.93
Novel UBE3A mutations causing Angelman syndrome: different parental origin for single nucleotide changes and multiple nucleotide deletions or insertions. Am J Med Genet A (2009) 0.93
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. Nephrol Dial Transplant (2013) 0.93
Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant (2012) 0.92
BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol (2010) 0.92
Klotho modulates the stress response in human senescent endothelial cells. Mech Ageing Dev (2012) 0.92
Application of the new cholesterol guidelines. N Engl J Med (2014) 0.92
MR arthrography of the shoulder using an anterior approach: optimal injection site. AJR Am J Roentgenol (2008) 0.91
Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice. Nephrol Dial Transplant (2012) 0.91
Paricalcitol for reduction of albuminuria in diabetes. Lancet (2011) 0.91
Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. Nephrol Dial Transplant (2011) 0.91
TWEAK and the progression of renal disease: clinical translation. Nephrol Dial Transplant (2014) 0.91
Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled. Int Urol Nephrol (2012) 0.91
MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors. J Cancer Res Clin Oncol (2008) 0.91
Haematuria: the forgotten CKD factor? Nephrol Dial Transplant (2012) 0.91
Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract (2012) 0.91
A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI. BMC Syst Biol (2013) 0.90